Hypermarcas (OTCMKTS:HYPMY) Shares Gap Up – Should You Buy?

Hypermarcas (OTCMKTS:HYPMY)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $3.81, but opened at $4.0510. Hypermarcas shares last traded at $4.0510, with a volume of 8,913 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Hypermarcas currently has a consensus rating of “Buy”.

Hypermarcas Price Performance

The company has a debt-to-equity ratio of 0.61, a current ratio of 1.27 and a quick ratio of 0.84. The company has a market capitalization of $2.92 billion, a PE ratio of 8.65 and a beta of 0.70. The firm has a 50-day moving average of $4.42 and a 200 day moving average of $4.41.

Hypermarcas (OTCMKTS:HYPMY) last issued its earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%.The business had revenue of $383.13 million during the quarter. As a group, research analysts anticipate that Hypermarcas will post 0.53 earnings per share for the current fiscal year.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.